2021
DOI: 10.1016/j.jaad.2021.04.032
|View full text |Cite
|
Sign up to set email alerts
|

Elevated serum levels of C-X-C motif chemokine ligand 10 can distinguish systemic lupus erythematosus patients from cutaneous lupus erythematosus patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 5 publications
1
2
0
Order By: Relevance
“…In addition, we also observed increases in a large number of C‐C motif chemokines, including Ccl19 [13.4‐fold], Ccl21a [5.2‐fold], Ccl8 [3.7‐fold], Ccl6 [2.6‐fold] in NativeMP3. Consistent with this increase in chemokines, increased plasma concentrations of many inflammatory chemokines have previously been reported in patients with systemic lupus erythematosus [26, 27]. It has been proposed that chemokine receptors (e.g., Cxcr3) play a crucial role in directing pathogenic effector T cells to the kidney in MRL‐lpr mice [28].…”
Section: Resultssupporting
confidence: 58%
See 1 more Smart Citation
“…In addition, we also observed increases in a large number of C‐C motif chemokines, including Ccl19 [13.4‐fold], Ccl21a [5.2‐fold], Ccl8 [3.7‐fold], Ccl6 [2.6‐fold] in NativeMP3. Consistent with this increase in chemokines, increased plasma concentrations of many inflammatory chemokines have previously been reported in patients with systemic lupus erythematosus [26, 27]. It has been proposed that chemokine receptors (e.g., Cxcr3) play a crucial role in directing pathogenic effector T cells to the kidney in MRL‐lpr mice [28].…”
Section: Resultssupporting
confidence: 58%
“…In [26,27]. It has been proposed that chemokine receptors (e.g., Cxcr3) play a crucial role in directing pathogenic effector T cells to the kidney in MRL-lpr mice [28].…”
Section: Analysis Of Mrl-lpr Plasma Using Automp3 and Nativemp3mentioning
confidence: 99%
“…The interaction between CXCR3-expressing T-cells and its ligands CXCL9, CXCL10 and CXCL11 have been associated with tissue damage in several CLE subtypes( 8 ). A recent study described CXCL10 as a biomarker that can distinguish CLE patients from systemic lupus patients( 34 ). Based on our data, we would hypothesize that CXCL11 may be a superior biomarker to CXCL10 in predicting disease activity in CLE patients due to both its expression level and chemotactic potency, though this would need to be validated in a larger patient cohort.…”
Section: Discussionmentioning
confidence: 99%